Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Inclusion criteria

• Adults (45 years or older) who have confirmed age-related cataracts and are eligible for bilateral cataract surgery.
• Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK.
• Patients who have regular corneal astigmatism less than or equal to 0.6 D and are candidates for the PanOptix Pro spherical IOL.
• Patients who have regular corneal astigmatism and are candidates for PanOptix Pro toric IOL T3
• Postoperative visual potential of monocular 20/25 or better, in the surgeon's judgement.

Exclusion criteria

• Any ocular comorbidity that might hamper postoperative visual acuity:

• Corneal abnormality including corneal dystrophy, irregularity, and degeneration.
• Moderate or severe dry eyes that can't be relieved after treatment.
• History of or current anterior and posterior inflammation of any etiology.
• Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc.
• Glaucoma of any kind.
• Pregnancy or lactation.
• Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK).
• Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate)
• Apple Kappa/chord mu ≥ 0.6.
• Higher order corneal aberrations at pupil diameter of 4mm: > 0.6 total RMS, > 0.3 coma, > 0.3 trefoil (to exclude irregular corneas)
• Any patient requiring a limbal relaxing incision.

The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.